CYCS and lung carcinoma: XIAP, a key member of the inhibitor of apoptosis protein (IAP) family122, has been shown to be a direct inhibitor of caspase-3 and to interfere with the cytochrome-C pathway by inhibiting caspase-9 in lung cancer cells123–125, and leukemia cells126–129.